BARICICH, ALESSIO
 Distribuzione geografica
Continente #
AS - Asia 2.033
NA - Nord America 1.302
SA - Sud America 519
EU - Europa 222
AF - Africa 45
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.127
Nazione #
SG - Singapore 1.327
US - Stati Uniti d'America 1.250
BR - Brasile 440
CN - Cina 266
VN - Vietnam 207
HK - Hong Kong 55
IN - India 44
DE - Germania 33
IT - Italia 32
AR - Argentina 30
FR - Francia 25
GB - Regno Unito 24
CA - Canada 19
MX - Messico 18
PL - Polonia 18
RU - Federazione Russa 18
BD - Bangladesh 17
TR - Turchia 15
ID - Indonesia 14
ZA - Sudafrica 14
NL - Olanda 13
UZ - Uzbekistan 13
EC - Ecuador 12
MA - Marocco 11
ES - Italia 10
AT - Austria 9
IQ - Iraq 9
VE - Venezuela 9
CL - Cile 8
JP - Giappone 8
PY - Paraguay 8
UA - Ucraina 8
PK - Pakistan 7
SE - Svezia 7
CO - Colombia 6
JM - Giamaica 5
PH - Filippine 5
JO - Giordania 4
KZ - Kazakistan 4
MY - Malesia 4
NP - Nepal 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
KE - Kenya 3
KR - Corea 3
LT - Lituania 3
TN - Tunisia 3
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EG - Egitto 2
FI - Finlandia 2
HR - Croazia 2
IL - Israele 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CM - Camerun 1
GE - Georgia 1
GI - Gibilterra 1
HN - Honduras 1
IE - Irlanda 1
IR - Iran 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
NA - Namibia 1
OM - Oman 1
PA - Panama 1
SI - Slovenia 1
TG - Togo 1
TH - Thailandia 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 4.127
Città #
Singapore 558
San Jose 269
Ashburn 267
The Dalles 218
Dallas 134
Shanghai 88
Beijing 76
Ho Chi Minh City 76
Hong Kong 49
Hanoi 45
São Paulo 32
Los Angeles 29
Warsaw 17
Rio de Janeiro 16
New York 15
Milan 14
Prineville 13
Fort Worth 12
Haiphong 12
Orem 12
Montreal 11
Tashkent 11
Belo Horizonte 9
Atlanta 8
Buffalo 8
Chennai 8
Tokyo 8
Biên Hòa 7
Boston 7
Council Bluffs 7
Denver 7
Fortaleza 7
Guayaquil 7
Lauterbourg 7
Mexico City 7
Stockholm 7
Amsterdam 6
Charlotte 6
Curitiba 6
Düsseldorf 6
Johannesburg 6
Manchester 6
Mumbai 6
Recife 6
Santa Clara 6
Brooklyn 5
Caracas 5
Caxias do Sul 5
Chicago 5
Hải Dương 5
London 5
Marília 5
Ninh Bình 5
Porto Alegre 5
Quito 5
Amman 4
Ankara 4
Anápolis 4
Baghdad 4
Brasília 4
Campinas 4
Frankfurt am Main 4
Maceió 4
Niterói 4
Nuremberg 4
Phoenix 4
Poplar 4
Reston 4
San Francisco 4
Santiago 4
Sorocaba 4
Springfield 4
São José dos Campos 4
Vienna 4
Addis Ababa 3
Athens 3
Buenos Aires 3
Bắc Ninh 3
Campo Grande 3
Cape Town 3
Caratinga 3
Casablanca 3
Ciudad del Este 3
Da Nang 3
Delhi 3
Goiânia 3
Guarulhos 3
Itajaí 3
Jackson 3
Kathmandu 3
Kingston 3
Limeira 3
Manaus 3
Marrakesh 3
Munich 3
Osasco 3
Praia Grande 3
Salvador 3
Santa Luzia 3
Santo André 3
Totale 2.336
Nome #
ROLE OF EARLY BOTULINUM TOXIN TYPE A INJECTION IN THE TREATMENT OF PATIENTS WITH POSTSTROKE SPASTICITY: PRELIMINARY RESULTS OF AN OBSERVATIONAL STUDY 89
La valutazione dell’outcome nel percorso riabilitativo della protesi di ginocchio 81
RIEDUCAZIONE DEL CAMMINO NEL MORBO DI PARKINSON: TRATTAMENTO ROBOTIZZATO VERSUS TRAINING SU TREADMILL. STUDIO RANDOMIZZATO CONTROLLATO 69
Post-stroke spasticity: follow-up and functional implications of chronic long-term treatment with botulinum toxin 68
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 66
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 55
What is the impact of robotic rehabilitation on balance and gait outcomes in people with multiple sclerosis? A systematic review of randomized control trials 52
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN POST-STROKE PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 49
Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals? 49
Valutazione comparativa di tre diversi protocolli riabilitativi post-inoculo di tossina botulinica A sull’ipertono spastico dell’arto inferiore 47
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature 47
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 47
Adherence to onabotulinumtoxina treatment in multiple sclerosis patients with spasticity from the aspire study 47
Variations of muscle activity patterns in free weight versus flywheel resistance front squat: a pilot study 46
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study 46
Balance Rehabilitation through Robot-Assisted Gait Training in Post-Stroke Patients: A Systematic Review and Meta-Analysis 46
Botulinum Toxin for Pain Relief in Cancer Patients: A Systematic Review of Randomized Controlled Trials 45
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach 45
Robotic gait training is not superior to conventional treadmill training in Parkinson's Disease: A single-blind randomized controlled trial 45
Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study 45
Abobotulinumtoxina and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis 45
Capitolo "Strumenti di cura: Programma farmacologico" in: Foti C, Monticone M. "Manuale di medicina fisica e riabilitativa". EDRA, Milano, 2021 45
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 44
Accurate gait analysis in post-stroke patients using a single inertial measurement unit 44
Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study 44
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 44
A Rare Cause of Back Pain During Pregnancy and Lactation: Management and Treatment 44
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up 43
Buccal hemineglect: is it useful to evaluate the differences between the two halves of the oral cavity for the multidisciplinary rehabilitative management of right brain stroke survivors? A cross-sectional study 43
Low back pain related to a sacral insufficiency fracture: Role of paravertebral oxygen-ozone therapy in a paradigmatic case of nociplastic pain 43
Ageing, functioning patterns and their environmental determinants in the spinal cord injury (SCI) population: A comparative analysis across eleven European countries implementing the International Spinal Cord Injury Community Survey 43
Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: An observational study 42
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke 42
ABOBOTULINUMTOXINA AND REHABILITATION VERSUS REHABILITATION ALONE IN POSTSTROKE SPASTICITY: AN ITALIAN COST-UTILITY ANALYSIS 42
Identification of Factors that Impact Adherence to OnabotulinumtoxinA Treatment for Spasticity in Post-Stroke and Multiple Sclerosis Patients from ASPIRE 41
Evaluation of the safety profile of intra-articular treatment with Oxygen-Ozone therapy in knee arthrosis: controlled randomized study 40
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 40
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity 40
Pain, disability, and quality of life in participants after concurrent onabotulinumtoxinA treatment of upper and lower limb spasticity: Observational results from the ASPIRE study 39
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 39
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 39
Urgent Measures for the Containment of the Coronavirus (Covid-19) Epidemic in the Neurorehabilitation/Rehabilitation Departments in the Phase of Maximum Expansion of the Epidemic 39
A single-blinded,randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot 39
The value of adding mirror therapy for upper limb motor recovery of subacute stroke patients: a randomized controlled trial 38
Long-lasting consequences of Coronavirus disease 19 pneumonia: a systematic review 38
Recovery from vegetative state of patients with a severe brain injury: a 4-year real-practice prospective cohort study 37
Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients 37
Role of Diagnostic Nerve Blocks in the Goal-Oriented Treatment of Spasticity with Botulinum Toxin Type A: A Case–Control Study 37
Sensor based assessment of turning during instrumented Timed Up and Go Test for quantifying mobility in chronic stroke patients 37
Confronto randomizzato, controllato in doppio cieco tra casting e taping nel trattamento riabilitativo dopo tossina botulinica A 37
RE: Impact of instrumental analysis of stiff knee gait on treatment appropriateness and associated costs in stroke patients 37
Differentiation among bio- and augmented- feedback in technologically assisted rehabilitation 36
Heart rate variability (hrv) modifications in adult hemiplegic patients after botulinum toxin type a (nt-201) injection 36
Heart Rate Variability modifications induced by high doses of incobotulinumtoxinA and onabotulinumtoxinA in hemiplegic chronic stroke patients: A single blind randomized controlled, crossover pilot study 36
The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study 36
Editorial: Long term disability in neurological disease: A rehabilitation perspective 36
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 35
Triceps surae muscle characteristics in spastic hemiparetic stroke survivors treated with botulinum toxin type a: Clinical implications from ultrasonographic evaluation 35
Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights From the ASPIRE Study 35
Administration of type a botulinum toxin after total hip replacement 35
Post-stroke spasticity as a condition: A new perspective on patient evaluation 35
Sarcopenic dysphagia: a narrative review 34
Spasticity Treatment During COVID-19 Pandemic: Clinical Recommendations 34
Short-wave diathermy for spastic equinus foot in chronic stroke patients: a proof-of-concept pilot study 34
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 34
Robotic gait training is not superior to conventional treadmill training in parkinson disease: a single-blind randomized controlled trial 34
Can scoliosis lead to spinal cord ischaemia? Early diagnosis and rehabilitation: A paradigmatic case report and literature review 33
Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis 33
Does altering inclination alter effectiveness of treadmill training for gait impairment after stroke? A randomized controlled trial 32
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 32
The Italian real-life post-stroke spasticity survey: unmet needs in the management of spasticity with botulinum toxin type A 32
High-Intensity Exercise Training Impact on Cardiorespiratory Fitness, Gait Ability, and Balance in Stroke Survivors: A Systematic Review and Meta-Analysis 32
Long-Term Spasticity Management in Post-Stroke Patients: Issues and Possible Actions-A Systematic Review with an Italian Expert Opinion 32
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 32
Optimization of transdisciplinary management of elderly with femur proximal extremity fracture: A patient-tailored plan from orthopaedics to rehabilitation 32
Effects of robot-assisted gait training on postural instability in parkinson's disease: A systematic review 32
Power Doppler Ultrasound Findings before and after Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Pilot Study on Pain Reduction and Neovascularization Effect 32
A new mutation in the CAVIN1/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature 32
Early botulinum toxin type a injection for post-stroke spasticity: A longitudinal cohort study 31
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 31
From paper to informatics: the Post Soft Care-App, an easy-to-use and fast tool to help therapists identify unmet needs in stroke patients 31
Peripheral facial nerve palsy: how effective is rehabilitation? 31
The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis 31
Rectus femoris characteristics in post stroke spasticity: Clinical implications from ultrasonographic evaluation 31
People with Spinal Cord Injury in Italy 31
Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study 31
Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study 31
Management of stroke patients submitted to botulinum toxin type a therapy: A Delphi survey of an Italian expert panel of specialist injectors 30
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment 30
Indicatori di qualità per la continuità delle cure in Medicina Riabilitativa 30
Development of new biomarkers in the prevention of lymphedema related to breast cancer: a multidisciplinary challenge 30
IS THE OUTCOME OF DIAGNOSTIC NERVE BLOCK RELATED TO SPASTIC MUSCLE ECHO INTENSITY? A RETROSPECTIVE OBSERVATIONAL STUDY ON PATIENTS WITH SPASTIC EQUINOVARUS FOOT 30
Is the Silfverskiöld Test a valid tool for evaluating calf muscles spastic overactivity in patients with stroke? A retrospective observational study 29
Falls, fractures and bone density in Parkinson’s disease–a cross-sectional study 29
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 29
Is spasticity always the same? An observational study comparing the features of spastic equinus foot in patients with chronic stroke and multiple sclerosis 29
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 29
Multidimensional Effectiveness of Botulinum Toxin in Neuropathic Pain: A Systematic Review of Randomized Clinical Trials 29
High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis 28
Post Soft Care: Italian implementation of a post-stroke checklist software for primary care and identification of unmet needs in community-dwelling patients 28
Totale 3.916
Categoria #
all - tutte 21.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.439 0 0 208 71 24 165 74 75 233 302 144 143
2025/20262.812 425 279 210 250 133 167 878 164 183 123 0 0
Totale 4.251